Showing results (211-220 of 397) with videos related to
Sort By:
Pageof 40
The New England Journal of Medicine|November 24, 1988
Antenatal treatment of neonatal alloimmune thrombocytopeniaJ B Bussel, R L Berkowitz, J G McFarland, et al.Obstetrics and Gynecology|July 1, 1992
Antenatal treatment of alloimmune thrombocytopeniaL Lynch, J B Bussel, J G McFarland, et al.Ejhaem|May 19, 2023
Overuse of corticosteroids in patients with immune thrombocytopenia (ITP) between 2011 and 2017 in the United StatesAdam Cuker, Joseph Tkacz, Janna Manjelievskaia, et al.American Journal of Hematology|May 26, 2016
Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopeniaJohn Chapin, Christina S Lee, Haiyu Zhang, et al.Blood|April 28, 2009
The ITP syndrome: pathogenic and clinical diversityDouglas B Cines, James B Bussel, Howard A Liebman, et al.American Journal of Hematology|August 28, 2007
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpuraRobert McMillan, James B Bussel, James N George, et al.Blood|December 20, 2008
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of SykAnna Podolanczuk, Alan H Lazarus, Andrew R Crow, et al.Spinal Cord|March 1, 1997
Endothelial fibrinolytic reactivity and the risk of deep venous thrombosis after spinal cord injuryL Boudaoud, J Roussi, S Lortat-Jacob, et al.Journal of Pediatric Hematology/Oncology|June 17, 1998
BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpuraS Gururangan, J G McFarland, D B Cines, et al.Neurorehabilitation and Neural Repair|February 21, 2009
Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticityD Bensmail, A B Ward, J Wissel, et al.Pageof 40